logo-loader

BP, Greggs, Guinness owner and more: Day ahead on Tuesday

Published: 16:00 29 Jul 2024 BST

bp

Can BP change the minds of analysts at JP Morgan... read more

St James Place's update is expected to  contain a myriad of risks... read more

Guinness owner Diageo PLC is expected to report another slide in earnings in its full-year results... read more

Will Greggs continue charging forward in expansion mode? Last week's announcement seems to say so... read more

Announcements due:

Trading updates: Barr (A.G.) PLC, Glencore PLC (LSE:GLEN), Sage Group PLC

Finals: Altitude Group PLC (AIM:ALT), Diageo PLC, Filtronic PLC (LSE:FTC), Games Workshop Group PLC (LSE:GAW)

Interims: Bodycote PLC, BP PLC (LSE:BP.), Croda International PLC (LSE:CRDA), Essentra PLC (LSE:ESNT), Greggs PLC (LSE:GRG), Inchcape PLC (LSE:INCH), Paragon Banking Group PLC (LSE:PAG), Pod Point Group Holdings PLC (LSE:PODP), Sabre Insurance Group PLC (LSE:SBRE), Staffline Group PLC (AIM:STAF), Standard Chartered PLC (LSE:STAN), Spectris PLC (LSE:SXS), ConvaTec Group PLC (LSE:CTEC), Fresnillo PLC (LSE:FRES), St James’s Place PLC. SEPLAT Energy PLC

AGMs: Albion Technology & General VCT PLC, Armadale Capital PLC (AIM:ACP), Aseana Properties Ltd, Cake Box Holdings PLC (AIM:CBOX), Challenger Energy Group PLC (AIM:CEG, OTC:BSHPF), Picton Property Income LD, Proton Motor Power Systems PLC (AIM:PPS), Severfield PLC, Tatton Asset Management PLC (AIM:TAM), Upland Resources (LSE:UPL) Limited, Vodafone Group PLC (LSE:VOD), Record PLC (LSE:REC), Telecom Plus PLC (LSE:TEP)

US earnings: Merck & Co, PayPal Holdings, Pfizer, Procter & Gamble, Advanced Micro Devices, Arista Networks, Lemonade, Microsoft Corp (NASDAQ:MSFT), Mondelez, Pinterest, Starbucks Corp (NASDAQ:SBUX, ETR:SRB)

Economic announcements: Business Climate Indicator (EU), Consumer Confidence (EU), Economic Sentiment Indicator (EU), GDP (Preliminary) (EU), Industrial Confidence (EU), Services Sentiment (EU), House Price Index (US), Consumer Confidence (US)

Immunic Therapeutics reaches major milestone with completion of ENSURE Trial...

Immunic Therapeutics Chief Medical Officer Dr Andreas Muehler joined Steve Darling from Proactive to announce two major developments for the company’s lead drug candidate, vidofludimus calcium (IMU-838)—a nuclear receptor-related 1 (Nurr1) activator currently being investigated for the treatment...

23 hours, 33 minutes ago
OSZAR »